Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Platelets and autoimmunity.
In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.
Association between functional CD24 polymorphisms and susceptibility to autoimmune diseases: A meta-analysis.
Platelets and neurovascular inflammation.
Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.
Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007.
Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01)
Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen.
STAT3 Activates miR-155 in Th17 cells and Acts in Concert to Promote Experimental Autoimmune Uveitis.
Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease.
Poppers toxic maculopathy misdiagnosed as atypical optic neuritis.
Quantitative Proteomic Analysis of Human Substantia Nigra in Alzheimer's Disease, Huntington's Disease and Multiple Sclerosis.
Patient Characteristics Associated with Medication Adherence.
Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis.
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.
[Ophthalmological Findings in Paediatric and Adolescent Multiple Sclerosis.]
Music mnemonics aid Verbal Memory and Induce Learning - Related Brain Plasticity in Multiple Sclerosis.
Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study.
Perspectives on Physical Activity Among People with Multiple Sclerosis Who Are Wheelchair Users: Informing the Design of Future Interventions.
Alemtuzumab for multiple sclerosis: a new age of immunotherapy.
Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial.
High cumulative JC virus seroconversion rate during long-term use of natalizumab.
Rituximab combination therapy in relapsing multiple sclerosis.

Pages